According to Pharma Mar's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.36. At the end of 2024 the company had a P/S ratio of 7.68.
Year | P/S ratio | Change |
---|---|---|
2024 | 7.68 | 64.8% |
2023 | 4.66 | -21.88% |
2022 | 5.97 | 36.67% |
2021 | 4.37 | -14.65% |
2020 | 5.12 |